Sulfur Hexafluoride

Sulfur hexafluoride. An inert gas used mainly as a test gas in respiratory physiology. Other uses include its injection in vitreoretinal surgery to restore the vitreous chamber and as a tracer in monitoring the dispersion and deposition of air pollutants.

Also Known As:

Networked: 190 relevant articles (14 outcomes, 13 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Quaia, Emilio: 5 articles (08/2012 - 06/2006)
2.	Hirano, Yoshio: 4 articles (01/2021 - 08/2011)
3.	Ogura, Yuichiro: 4 articles (01/2021 - 08/2011)
4.	Yasukawa, Tsutomu: 4 articles (01/2021 - 08/2011)
5.	Cova, Maria Assunta: 4 articles (08/2012 - 12/2007)
6.	Heindl, Ludwig M: 3 articles (01/2022 - 01/2019)
7.	Caporossi, Tomaso: 3 articles (11/2021 - 12/2019)
8.	Rizzo, Stanislao: 3 articles (11/2021 - 12/2019)
9.	Enders, Philip: 3 articles (03/2021 - 01/2019)
10.	Barak, Yoreh: 3 articles (01/2019 - 01/2016)

Related Diseases

1.	Retinal Perforations 06/03/2016 - "The purpose of this study was to evaluate the anatomical and visual outcomes following macular hole surgery with 2 cc pure (100 %) sulfur hexafluoride (SF6) gas tamponade. " 07/20/2023 - "To evaluate the effect of room air and sulfur hexafluoride (SF6) gas in idiopathic macular hole(MH)surgery. " 01/01/2023 - "In-Office Sulfur Hexafluoride (SF6) Injection to Close Recently Operated or Reopened Macular Holes: A Minimal Approach Technique." 01/01/2022 - "To investigate whether air tamponade is noninferior to sulfur hexafluoride (SF6) gas tamponade for small (≤ 250 μm) and medium-sized (> 250 μm and ≤ 400 μm) macular holes (MHs). " 01/01/2022 - "Air versus Sulfur Hexafluoride Gas Tamponade for Small and Medium-Sized Macular Holes: A Randomized Noninferiority Trial."
2.	Retinal Detachment (Retinal Detachments) 01/01/2015 - "The use of sulfur hexafluoride helped revolutionize retinal detachment surgery and allowed for further advances in treating other posterior segment diseases." 05/01/1998 - "Intraoperative IOP and IOP immediately after sulfur hexafluoride (SF6) injection were monitored during pneumatic retinopexy in 22 eyes with rhegmatogenous retinal detachment. " 01/01/1991 - "Sulfur hexafluoride (SF6) is used for internal tamponade during retinal detachment surgery. " 01/01/1983 - "[Superior bullous retinal detachment: value of the intravitreous injection of sulfur hexafluoride]." 05/01/1981 - "The results of sulfur hexafluoride gas in retinal detachment surgery."
3.	Hemorrhage 01/01/2012 - "Pneumatic displacement with 40-degree downward gaze positioning after intravitreal sulfur hexafluoride injection is useful to displace a submacular hemorrhage. " 04/22/2011 - "The subretinal hemorrhage was successfully displaced by injecting intraocular sulfur hexafluoride (SF(6)) gas. " 12/01/1999 - "Management of submacular hemorrhage with intravitreal sulfur hexafluoride: a pilot study." 05/01/2009 - "After waiting for 45 days, without hemorrhage resolution, the patient received an intravitreal injection of sulfur hexafluoride gas and tPA; an almost complete hemorrhage absorption occurred after a week as well as a considerable improvement of visual acuity. " 12/01/1999 - "We carried out a pilot study to evaluate the efficacy of intravitreally administered sulfur hexafluoride (SF6) gas alone in the management of large submacular hemorrhages secondary to age-related macular degeneration (AMD). "
4.	Macular Degeneration (Age-Related Maculopathy) 08/01/2017 - "We report the outcomes of three consecutive patients with optic disc pit-associated maculopathy who were treated with 25-gauge pars plana vitrectomy, internal limiting membrane (ILM) peeling, fluid-air exchange, barrage endolaser, and sulfur hexafluoride (SF6) gas tamponade. " 12/01/1999 - "We carried out a pilot study to evaluate the efficacy of intravitreally administered sulfur hexafluoride (SF6) gas alone in the management of large submacular hemorrhages secondary to age-related macular degeneration (AMD). " 12/01/2001 - "Forty-seven patients with age-related macular degeneration underwent excision of CNVs following vitrectomy and tamponade with sulfur hexafluoride (SF6) or silicone oil. " 01/01/2000 - "To assess the efficacy and safety of intravitreal injection of recombinant tissue plasminogen activator and sulfur hexafluoride gas for displacement of subretinal hemorrhages in patients with age-related macular degeneration. " 07/01/2008 - "To describe the safety and efficacy of intravitreal tissue plasminogen activator (tPA) and sulfur hexafluoride (SF6) gas with sequential photodynamic therapy (PDT) in the management of submacular hemorrhage (SMH) associated with macular degeneration (MD). "
5.	Focal Nodular Hyperplasia 01/01/2020 - "The purpose of this article is to compare contrast-enhanced sonography (CEUS) with sulfur hexafluoride with MRI with the liver-specific contrast agent gadobenate dimeglumine in the diagnosis of hepatocellular adenoma (HCA) and focal nodular hyperplasia (FNH) in a cohort of consecutive patients. " 10/01/2021 - "This study aimed to compare the diagnostic efficacy of contrast-enhanced ultrasound (CEUS), including SonoVue (SV; sulfur hexafluoride; Bracco SpA, Milan, Italy) and Sonazoid (SZ; perflubutane; GE Healthcare, Oslo, Norway), and explore the differences between them in the characterization of CEUS features in focal nodular hyperplasia (FNH) smaller than 3 cm. "

Related Drugs and Biologics

1.	Tissue Plasminogen Activator (Alteplase)
2.	Silicone Oils
3.	contrast agent BR1
4.	perfluorobutane (AI 700)
5.	Sonazoid
6.	Hyaluronic Acid (Hyaluronan)
7.	1-phenyl-3,3-dimethyltriazene (PDT)
8.	Contrast Media
9.	Granulocyte Colony-Stimulating Factor (G-CSF)
10.	Anti-Bacterial Agents (Antibiotics)

Related Therapies and Procedures

1.	Vitrectomy
2.	Endotamponade
3.	Intravitreal Injections
4.	Photochemotherapy (Photodynamic Therapy)
5.	Scleral Buckling